PALI

Palisade Bio (PALI)

About Palisade Bio (PALI)

Palisade Bio, Inc. is a biopharmaceutical company, which engages in the development of oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. It offers LB1148, an oral formulation of a broad-spectrum serine protease inhibitor designed to neutralize the activity of potent digestive proteases released from the gut during surgery. The company was founded on September 6, 2011 and is headquartered in Carlsbad, CA.

Details

Daily high
$3.47
Daily low
$3.46
Price at open
$3.50
52 Week High
$22.35
52 Week Low
$3.14
Market cap
4.2M
Dividend yield
0.00%
Volume
145
Avg. volume
22,657
P/E ratio
-.18

Palisade Bio News

Details

Daily high
$3.47
Daily low
$3.46
Price at open
$3.50
52 Week High
$22.35
52 Week Low
$3.14
Market cap
4.2M
Dividend yield
0.00%
Volume
145
Avg. volume
22,657
P/E ratio
-.18